Screener
Castle Biosciences CSTL Geographic — Total Assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
Total assets for our reportable segment were located in the U.S. and were $547.8 million and $578.6 million as of March 31, 2026 and December 31, 2025, respectively. Expenditures for additions to long-lived assets were $5.2 million and $5.7 million for the three months ended March 31, 2026, and 2025, respectively.
Item 1. Financial Statements.
FAQ
- What is Castle Biosciences's geographic — total assets?
- Castle Biosciences (CSTL) reported geographic — total assets of $547.8M in Q1 2026.
- How has Castle Biosciences's geographic — total assets changed year-over-year?
- Castle Biosciences's geographic — total assets increased by 9.2% year-over-year, from $501.7M to $547.8M.
- What does geographic — total assets mean?
- This metric represents the total economic resources and property owned by the company that are located within the United States. It reflects the geographic concentration of capital investments, equipment, and operational infrastructure supporting the company's domestic commercial activities. Tracking this value helps investors assess the company's physical footprint and asset allocation strategy within its primary market.
Ask your AI about Castle Biosciences's geographic — total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude